{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:05:21Z","timestamp":1788458721407,"version":"build-2803163510"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myocarditis has been discovered to be a significant complication of coronavirus disease 2019 (COVID-19), a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. COVID-19 myocarditis seems to have distinct inflammatory characteristics, which make it unique to other viral etiologies. The incidence of COVID-19 myocarditis is still not clear as a wide range of figures have been quoted in the literature; however, it seems that the risk of developing myocarditis increases with more severe infection. Furthermore, the administration of the mRNA COVID-19 vaccine has been associated with the development of myocarditis, particularly after the second dose. COVID-19 myocarditis has a wide variety of presentations, ranging from dyspnea and chest pain to acute heart failure and possibly death. It is important to catch any cases of myocarditis, particularly those presenting with fulminant myocarditis which can be characterized by signs of heart failure and arrythmias. Initial work up for suspected myocarditis should include serial troponins and electrocardiograms. If myocardial damage is detected in these tests, further screening should be carried out. Cardiac magnetic resonance imagining and endomyocardial biopsy are the most useful tests for myocarditis. Treatment for COVID-19 myocarditis is still controversial; however, the use of intravenous immunoglobulins and corticosteroids in combination may be effective, particularly in cases of fulminant myocarditis. Overall, the incidence of COVID-19 myocarditis requires further research, while the use of intravenous immunoglobulins and corticosteroids in conjunction requires large randomized controlled trials to determine their efficacy.\n<\/jats:p>","DOI":"10.1186\/s43044-022-00260-2","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:07:51Z","timestamp":1649153271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["COVID-19 and myocarditis: a review of literature"],"prefix":"10.1186","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3933-0333","authenticated-orcid":false,"given":"Mohammed","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haaris A.","family":"Shiwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Y.","family":"Elfaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moaz","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebabonye","family":"Pharithi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Kamgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian BinounA","family":"Egom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis Essame","family":"Oyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel Eroume-A","family":"Egom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"issue":"5","key":"260_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong E, Du H, Gardner L (2020) An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20(5):533\u2013534. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1","journal-title":"Lancet Infect Dis"},{"key":"260_CR2","unstructured":"Cascella M, Rajnik M, Aleem A, Dulebohn SC, di Napoli R (2021)Features, Evaluation, and Treatment of Coronavirus (COVID-19)"},{"key":"260_CR3","unstructured":"WHO Coronavirus (COVID-19) Dashboard. Covid19.who.int. Accessed September 13, 2021. https:\/\/covid19.who.int\/"},{"issue":"1147","key":"260_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/postgradmedj-2020-138577","volume":"97","author":"A Parasher","year":"2021","unstructured":"Parasher A (2021) COVID-19: current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J 97(1147):312. https:\/\/doi.org\/10.1136\/postgradmedj-2020-138577","journal-title":"Postgrad Med J"},{"issue":"6965","key":"260_CR5","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"W Li","year":"2003","unstructured":"Li W, Moore MJ, Vasilieva N et al (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965):450\u2013454. https:\/\/doi.org\/10.1038\/nature02145","journal-title":"Nature"},{"issue":"6","key":"260_CR6","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/v4061011","volume":"4","author":"S Belouzard","year":"2012","unstructured":"Belouzard S, Millet JK, Licitra BN, Whittaker GR (2012) Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4(6):1011\u20131033. https:\/\/doi.org\/10.3390\/v4061011","journal-title":"Viruses"},{"issue":"8","key":"260_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324(8):782\u2013793. https:\/\/doi.org\/10.1001\/jama.2020.12839","journal-title":"JAMA"},{"issue":"5","key":"260_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s11739-021-02635-w","volume":"16","author":"D Mele","year":"2021","unstructured":"Mele D, Flamigni F, Rapezzi C, Ferrari R (2021) Myocarditis in COVID-19 patients: current problems. Intern Emerg Med 16(5):1123\u20131129. https:\/\/doi.org\/10.1007\/s11739-021-02635-w","journal-title":"Intern Emerg Med"},{"issue":"5","key":"260_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.33963\/KP.15888","volume":"79","author":"K Marcinkiewicz","year":"2021","unstructured":"Marcinkiewicz K, Petryka-Mazurkiewicz J, Nowicki M et al (2021) Acute heart failure in the course of fulminant myocarditis requiring mechanical circulatory support in a healthy young patient after coronavirus disease 2019. Kardiologia Polska (Polish Heart J) 79(5):583\u2013584. https:\/\/doi.org\/10.33963\/KP.15888","journal-title":"Kardiologia Polska (Polish Heart J)"},{"issue":"7","key":"260_CR10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","volume":"5","author":"RM Inciardi","year":"2020","unstructured":"Inciardi RM, Lupi L, Zaccone G et al (2020) Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(7):819\u2013824. https:\/\/doi.org\/10.1001\/jamacardio.2020.1096","journal-title":"JAMA Cardiol"},{"issue":"7","key":"260_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.14740\/jmc3517","volume":"11","author":"G Pascariello","year":"2020","unstructured":"Pascariello G, Cimino G, Calvi E et al (2020) Cardiogenic shock due to COVID-19-related myocarditis in a 19-year-old autistic patient. J Med Cases 11(7):207\u2013210. https:\/\/doi.org\/10.14740\/jmc3517","journal-title":"J Med Cases"},{"issue":"15","key":"260_CR12","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMra0800028","volume":"360","author":"LT Cooper Jr","year":"2009","unstructured":"Cooper LT Jr (2009) Myocarditis. N Engl J Med 360(15):1526\u20131538. https:\/\/doi.org\/10.1056\/NEJMra0800028","journal-title":"N Engl J Med"},{"issue":"6","key":"260_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/hrt.78.6.539","volume":"78","author":"C Baboonian","year":"1997","unstructured":"Baboonian C, Treasure T (1997) Meta-analysis of the association of enteroviruses with human heart disease. Heart (British Cardiac Society) 78(6):539\u2013543. https:\/\/doi.org\/10.1136\/hrt.78.6.539","journal-title":"Heart (British Cardiac Society)"},{"issue":"11","key":"260_CR14","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/eurheartj\/ehm076","volume":"28","author":"ALP Caforio","year":"2007","unstructured":"Caforio ALP, Calabrese F, Angelini A et al (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28(11):1326\u20131333. https:\/\/doi.org\/10.1093\/eurheartj\/ehm076","journal-title":"Eur Heart J"},{"issue":"7","key":"260_CR15","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1128\/JVI.03427-14","volume":"89","author":"AS Agrawal","year":"2015","unstructured":"Agrawal AS, Garron T, Tao X et al (2015) Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol 89(7):3659\u20133670. https:\/\/doi.org\/10.1128\/JVI.03427-14","journal-title":"J Virol"},{"issue":"1","key":"260_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev.pathmechdis.3.121806.151534","volume":"3","author":"M Esfandiarei","year":"2008","unstructured":"Esfandiarei M, McManus BM (2008) Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 3(1):127\u2013155. https:\/\/doi.org\/10.1146\/annurev.pathmechdis.3.121806.151534","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"260_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/(SICI)1096-9896(199709)183:1<105::AID-PATH1094>3.0.CO;2-E","volume":"183","author":"Y Seko","year":"1997","unstructured":"Seko Y, Takahashi N, Yagita H, Okumura K, Yazaki Y (1997) Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus B3. J Pathol 183(1):105\u2013108. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199709)183:1%3c105::AID-PATH1094%3e3.0.CO;2-E","journal-title":"J Pathol"},{"key":"260_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1385\/1-59259-805-6:175","volume":"102","author":"D Cihakova","year":"2004","unstructured":"Cihakova D, Sharma R, Fairweather D, Afanasyeva M, Rose N (2004) Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol Med 102:175\u2013193. https:\/\/doi.org\/10.1385\/1-59259-805-6:175","journal-title":"Methods Mol Med"},{"issue":"1","key":"260_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4049\/jimmunol.0800861","volume":"183","author":"P Zhang","year":"2009","unstructured":"Zhang P, Cox CJ, Alvarez KM, Cunningham MW (2009) Cutting edge: cardiac myosin activates innate immune responses through TLRs. J Immunol (Baltimore, Md) 183(1):27\u201331. https:\/\/doi.org\/10.4049\/jimmunol.0800861","journal-title":"J Immunol (Baltimore, Md)"},{"issue":"9","key":"260_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1161\/CIRCRESAHA.109.199802","volume":"105","author":"P Blyszczuk","year":"2009","unstructured":"Blyszczuk P, Kania G, Dieterle T et al (2009) Myeloid differentiation factor-88\/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy. Circ Res 105(9):912\u2013920. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.199802","journal-title":"Circ Res"},{"issue":"10","key":"260_CR21","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.109.213157","volume":"106","author":"GC Baldeviano","year":"2010","unstructured":"Baldeviano GC, Barin JG, Talor Mv et al (2010) Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circul Res 106(10):1646\u20131655. https:\/\/doi.org\/10.1161\/CIRCRESAHA.109.213157","journal-title":"Circul Res"},{"issue":"12","key":"260_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.12691\/ajmcr-8-12-19","volume":"8","author":"F Oleszak","year":"2020","unstructured":"Oleszak F, Maryniak A, Botti E et al (2020) Myocarditis associated With COVID-19. Am J Med Case Rep 8(12):498\u2013502. https:\/\/doi.org\/10.12691\/ajmcr-8-12-19","journal-title":"Am J Med Case Rep"},{"issue":"6","key":"260_CR23","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1165\/rcmb.2012-0339OC","volume":"48","author":"Z Qian","year":"2013","unstructured":"Qian Z, Travanty EA, Oko L et al (2013) Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol 48(6):742\u2013748. https:\/\/doi.org\/10.1165\/rcmb.2012-0339OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"260_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1741-7015-2-19","volume":"2","author":"AB Goulter","year":"2004","unstructured":"Goulter AB, Goddard MJ, Allen JC, Clark KL (2004) ACE2 gene expression is up-regulated in the human failing heart. BMC Med 2:19. https:\/\/doi.org\/10.1186\/1741-7015-2-19","journal-title":"BMC Med"},{"issue":"1 & 2","key":"260_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ijmr.IJMR_2450_20","volume":"153","author":"YP Sharma","year":"2021","unstructured":"Sharma YP, Agstam S, Yadav A, Gupta A, Gupta A (2021) Cardiovascular manifestations of COVID-19: an evidence-based narrative review. Indian J Med Res 153(1 & 2):7\u201316. https:\/\/doi.org\/10.4103\/ijmr.IJMR_2450_20","journal-title":"Indian J Med Res"},{"issue":"5","key":"260_CR26","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/ejhf.1828","volume":"22","author":"G Tavazzi","year":"2020","unstructured":"Tavazzi G, Pellegrini C, Maurelli M et al (2020) Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 22(5):911\u2013915. https:\/\/doi.org\/10.1002\/ejhf.1828","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"260_CR27","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","volume":"39","author":"GY Oudit","year":"2009","unstructured":"Oudit GY, Kassiri Z, Jiang C et al (2009) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest 39(7):618\u2013625. https:\/\/doi.org\/10.1111\/j.1365-2362.2009.02153.x","journal-title":"Eur J Clin Invest"},{"issue":"9","key":"260_CR28","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.hrthm.2020.05.001","volume":"17","author":"B Siripanthong","year":"2020","unstructured":"Siripanthong B, Nazarian S, Muser D et al (2020) Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 17(9):1463\u20131471. https:\/\/doi.org\/10.1016\/j.hrthm.2020.05.001","journal-title":"Heart Rhythm"},{"issue":"3","key":"260_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jacc.2020.11.031","volume":"77","author":"R Kawakami","year":"2021","unstructured":"Kawakami R, Sakamoto A, Kawai K et al (2021) Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J Am Coll Cardiol 77(3):314\u2013325. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.031","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"260_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.120.049465","volume":"142","author":"SE Fox","year":"2020","unstructured":"Fox SE, Li G, Akmatbekov A et al (2020) Unexpected features of cardiac pathology in COVID-19 infection. Circulation 142(11):1123\u20131125. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.049465","journal-title":"Circulation"},{"issue":"10234","key":"260_CR31","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet (London, England) 395(10234):1417\u20131418. https:\/\/doi.org\/10.1016\/S0140-6736(20)30937-5","journal-title":"Lancet (London, England)"},{"key":"260_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2021.107361","volume":"54","author":"SE Fox","year":"2021","unstructured":"Fox SE, Falgout L, vandar Heide RS (2021) COVID-19 myocarditis: quantitative analysis of the inflammatory infiltrate and a proposed mechanism. Cardiovasc Pathol 54:107361. https:\/\/doi.org\/10.1016\/j.carpath.2021.107361","journal-title":"Cardiovasc Pathol"},{"issue":"2","key":"260_CR33","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee DW, Gardner R, Porter DL et al (2014) Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124(2):188\u2013195. https:\/\/doi.org\/10.1182\/blood-2014-05-552729","journal-title":"Blood"},{"key":"260_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","volume":"53","author":"F Coperchini","year":"2020","unstructured":"Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M (2020) The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system. Cytokine Growth Factor Rev 53:25\u201332. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.05.003","journal-title":"Cytokine Growth Factor Rev"},{"issue":"15","key":"260_CR35","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.jacc.2021.02.035","volume":"77","author":"AH Talasaz","year":"2021","unstructured":"Talasaz AH, Sadeghipour P, Kakavand H et al (2021) Recent randomized trials of antithrombotic therapy for patients with COVID-19: JACC state-of-the-art review. J Am Coll Cardiol 77(15):1903\u20131921. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.035","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"260_CR36","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik TJ, Mohiddin SA, Dimarco A et al (2020) COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 116(10):1666\u20131687. https:\/\/doi.org\/10.1093\/cvr\/cvaa106","journal-title":"Cardiovasc Res"},{"issue":"7","key":"260_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo T, Fan Y, Chen M et al (2020) Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(7):811\u2013818. https:\/\/doi.org\/10.1001\/jamacardio.2020.1017","journal-title":"JAMA Cardiol"},{"issue":"5","key":"260_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"B Li","year":"2020","unstructured":"Li B, Yang J, Zhao F et al (2020) Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 109(5):531\u2013538. https:\/\/doi.org\/10.1007\/s00392-020-01626-9","journal-title":"Clin Res Cardiol"},{"key":"260_CR39","doi-asserted-by":"publisher","first-page":"107300","DOI":"10.1016\/j.carpath.2020.107300","volume":"50","author":"MK Halushka","year":"2021","unstructured":"Halushka MK, vandar Heide RS (2021) Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol 50:107300. https:\/\/doi.org\/10.1016\/j.carpath.2020.107300","journal-title":"Cardiovasc Pathol"},{"issue":"11","key":"260_CR40","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","volume":"5","author":"VO Puntmann","year":"2020","unstructured":"Puntmann VO, Carerj ML, Wieters I et al (2020) Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(11):1265\u20131273. https:\/\/doi.org\/10.1001\/jamacardio.2020.3557","journal-title":"JAMA Cardiol"},{"issue":"7","key":"260_CR41","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","volume":"5","author":"S Shi","year":"2020","unstructured":"Shi S, Qin M, Shen B et al (2020) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 5(7):802\u2013810. https:\/\/doi.org\/10.1001\/jamacardio.2020.0950","journal-title":"JAMA Cardiol."},{"issue":"5","key":"260_CR42","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 46(5):846\u2013848. https:\/\/doi.org\/10.1007\/s00134-020-05991-x","journal-title":"Intensive Care Med"},{"issue":"8","key":"260_CR43","doi-asserted-by":"publisher","first-page":"e24552","DOI":"10.1097\/MD.0000000000024552","volume":"100","author":"N Lagan\u00e0","year":"2021","unstructured":"Lagan\u00e0 N, Cei M, Evangelista I et al (2021) Suspected myocarditis in patients with COVID-19: a multicenter case series. Medicine 100(8):e24552\u2013e24552. https:\/\/doi.org\/10.1097\/MD.0000000000024552","journal-title":"Medicine"},{"key":"260_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.695206","volume":"8","author":"F Omidi","year":"2021","unstructured":"Omidi F, Hajikhani B, Kazemi SN et al (2021) COVID-19 and cardiomyopathy: a systematic review. Front Cardiovasc Med 8:695206. https:\/\/doi.org\/10.3389\/fcvm.2021.695206","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"260_CR45","doi-asserted-by":"publisher","first-page":"9884","DOI":"10.1002\/jcp.29802","volume":"235","author":"J Guo","year":"2020","unstructured":"Guo J, Wei X, Li Q et al (2020) Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury. J Cell Physiol 235(12):9884\u20139894. https:\/\/doi.org\/10.1002\/jcp.29802","journal-title":"J Cell Physiol"},{"key":"260_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.628885","author":"M Ma","year":"2021","unstructured":"Ma M, Xu Y, Su Y et al (2021) Single-cell transcriptome analysis decipher new potential regulation mechanism of ACE2 and NPs signaling among heart failure patients infected with SARS-CoV-2. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.628885","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"260_CR47","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","volume":"116","author":"L Chen","year":"2020","unstructured":"Chen L, Li X, Chen M, Feng Y, Xiong C (2020) The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res 116(6):1097\u20131100. https:\/\/doi.org\/10.1093\/cvr\/cvaa078","journal-title":"Cardiovasc Res"},{"key":"260_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100404","volume":"23","author":"D Pan","year":"2020","unstructured":"Pan D, Sze S, Minhas JS et al (2020) The impact of ethnicity on clinical outcomes in COVID-19: a systematic review. EClinicalMedicine 23:100404. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100404","journal-title":"EClinicalMedicine"},{"issue":"10","key":"260_CR49","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamacardio.2018.2541","volume":"3","author":"VD Myers","year":"2018","unstructured":"Myers VD, Gerhard GS, McNamara DM et al (2018) Association of variants in BAG3 with cardiomyopathy outcomes in African American Individuals. JAMA Cardiol 3(10):929\u2013938. https:\/\/doi.org\/10.1001\/jamacardio.2018.2541","journal-title":"JAMA Cardiol"},{"issue":"2","key":"260_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11883-016-0559-4","volume":"18","author":"JA Leigh","year":"2016","unstructured":"Leigh JA, Alvarez M, Rodriguez CJ (2016) Ethnic minorities and coronary heart disease: an update and future directions. Curr Atheroscler Rep 18(2):9. https:\/\/doi.org\/10.1007\/s11883-016-0559-4","journal-title":"Curr Atheroscler Rep"},{"issue":"8","key":"260_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2020.100621","volume":"45","author":"E Abuelgasim","year":"2020","unstructured":"Abuelgasim E, Saw LJ, Shirke M, Zeinah M, Harky A (2020) COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities. Curr Probl Cardiol 45(8):100621. https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100621","journal-title":"Curr Probl Cardiol"},{"key":"260_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104361","volume":"84","author":"M Vinciguerra","year":"2020","unstructured":"Vinciguerra M, Greco E (2020) Sars-CoV-2 and black population: ACE2 as shield or blade? Infection Genetics Evol J Mol Epidemiol Evolut Genetics Infect Diseases 84:104361. https:\/\/doi.org\/10.1016\/j.meegid.2020.104361","journal-title":"Infection Genetics Evol J Mol Epidemiol Evolut Genetics Infect Diseases"},{"key":"260_CR53","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000239","author":"BJ Maron","year":"2015","unstructured":"Maron BJ, Udelson JE, Bonow RO et al (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000000239","journal-title":"Circulation"},{"key":"260_CR54","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2065","author":"CJ Daniels","year":"2021","unstructured":"Daniels CJ, Rajpal S, Greenshields JT et al (2021) Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2021.2065","journal-title":"JAMA Cardiol"},{"issue":"1","key":"260_CR55","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1001\/jamacardio.2020.4916","volume":"6","author":"S Rajpal","year":"2021","unstructured":"Rajpal S, Tong MS, Borchers J et al (2021) Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol 6(1):116\u2013118. https:\/\/doi.org\/10.1001\/jamacardio.2020.4916","journal-title":"JAMA Cardiol"},{"issue":"6","key":"260_CR56","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","volume":"144","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt B, Kamat I, Hotez PJ (2021) Myocarditis with COVID-19 mRNA vaccines. Circulation 144(6):471\u2013484. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056135","journal-title":"Circulation"},{"key":"260_CR57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13443","author":"GA Diaz","year":"2021","unstructured":"Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson Iv, Robicsek A (2021) Myocarditis and pericarditis after vaccination for COVID19. JAMA. https:\/\/doi.org\/10.1001\/jama.2021.13443","journal-title":"JAMA"},{"issue":"29","key":"260_CR58","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1016\/j.vaccine.2021.05.087","volume":"39","author":"S Abu Mouch","year":"2021","unstructured":"Abu Mouch S, Roguin A, Hellou E et al (2021) Myocarditis following COVID-19 mRNA vaccination. Vaccine 39(29):3790\u20133793. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.087","journal-title":"Vaccine"},{"key":"260_CR59","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2828","author":"HW Kim","year":"2021","unstructured":"Kim HW, Jenista ER, Wendell DC et al (2021) Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2021.2828","journal-title":"JAMA Cardiol"},{"issue":"9","key":"260_CR60","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.jcmg.2021.06.002","volume":"14","author":"KE Shaw","year":"2021","unstructured":"Shaw KE, Cavalcante JL, Han BK, G\u00f6ssl M (2021) Possible association between COVID-19 vaccine and myocarditis: clinical and CMR findings. JACC Cardiovasc Imaging 14(9):1856\u20131861. https:\/\/doi.org\/10.1016\/j.jcmg.2021.06.002","journal-title":"JACC Cardiovasc Imaging"},{"key":"260_CR61","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.2833","author":"J Montgomery","year":"2021","unstructured":"Montgomery J, Ryan M, Engler R et al (2021) Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2021.2833","journal-title":"JAMA Cardiol"},{"key":"260_CR62","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.3471","author":"A Dionne","year":"2021","unstructured":"Dionne A, Sperotto F, Chamberlain S et al (2021) Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2021.3471","journal-title":"JAMA Cardiol"},{"issue":"5","key":"260_CR63","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/S2352-4642(21)00066-3","volume":"5","author":"SS Bhopal","year":"2021","unstructured":"Bhopal SS, Bagaria J, Olabi B, Bhopal R (2021) Children and young people remain at low risk of COVID-19 mortality. Lancet Child Adolescent Health 5(5):e12\u2013e13. https:\/\/doi.org\/10.1016\/S2352-4642(21)00066-3","journal-title":"Lancet Child Adolescent Health"},{"key":"260_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2021.05.010","author":"T D\u2019Angelo","year":"2021","unstructured":"D\u2019Angelo T, Cattafi A, Carerj ML et al (2021) Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction? Can J Cardiol. https:\/\/doi.org\/10.1016\/j.cjca.2021.05.010","journal-title":"Can J Cardiol"},{"key":"260_CR65","unstructured":"Al-Akchar M, Kiel J (2021) Acute Myocarditis"},{"issue":"19","key":"260_CR66","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/eurheartj\/ehaa288","volume":"41","author":"IC Kim","year":"2020","unstructured":"Kim IC, Kim JY, Kim HA, Han S (2020) COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J 41(19):1859. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa288","journal-title":"Eur Heart J"},{"issue":"6","key":"260_CR67","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/children8060427","volume":"8","author":"BB Das","year":"2021","unstructured":"Das BB (2021) SARS-CoV-2 myocarditis in a high school athlete after COVID-19 and its implications for clearance for sports. Children (Basel, Switzerland) 8(6):427. https:\/\/doi.org\/10.3390\/children8060427","journal-title":"Children (Basel, Switzerland)"},{"issue":"23","key":"260_CR68","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/CIRCULATIONAHA.120.047164","volume":"141","author":"JA Fried","year":"2020","unstructured":"Fried JA, Ramasubbu K, Bhatt R et al (2020) The variety of cardiovascular presentations of COVID-19. Circulation 141(23):1930\u20131936. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047164","journal-title":"Circulation"},{"issue":"2","key":"260_CR69","doi-asserted-by":"publisher","first-page":"181","DOI":"10.31486\/toj.20.0090","volume":"21","author":"I Okor","year":"2021","unstructured":"Okor I, Sleem A, Zhang A, Kadakia R, Bob-Manuel T, Krim SR (2021) Suspected COVID-19-induced myopericarditis. Ochsner J 21(2):181\u2013186. https:\/\/doi.org\/10.31486\/toj.20.0090","journal-title":"Ochsner J"},{"issue":"6","key":"260_CR70","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.hrtlng.2020.08.013","volume":"49","author":"JS Ho","year":"2020","unstructured":"Ho JS, Sia CH, Chan MY, Lin W, Wong RC (2020) Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung J Crit Care 49(6):681\u2013685. https:\/\/doi.org\/10.1016\/j.hrtlng.2020.08.013","journal-title":"Heart Lung J Crit Care"},{"issue":"7","key":"260_CR71","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244027","volume":"14","author":"S Gaine","year":"2021","unstructured":"Gaine S, Devitt P, Coughlan JJ, Pearson I (2021) COVID-19-associated myocarditis presenting as new-onset heart failure and atrial fibrillation. BMJ Case Rep 14(7):e244027. https:\/\/doi.org\/10.1136\/bcr-2021-244027","journal-title":"BMJ Case Rep"},{"issue":"6","key":"260_CR72","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1161\/CIR.0000000000000745","volume":"141","author":"RD Kociol","year":"2020","unstructured":"Kociol RD, Cooper LT, Fang JC et al (2020) Recognition and initial management of fulminant myocarditis. Circulation 141(6):e69\u2013e92. https:\/\/doi.org\/10.1161\/CIR.0000000000000745","journal-title":"Circulation"},{"issue":"8","key":"260_CR73","doi-asserted-by":"publisher","first-page":"e14697","DOI":"10.1097\/MD.0000000000014697","volume":"98","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang Y, Lin H, Wang S, Cai X, Gao D (2019) Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: a meta-analysis. Medicine 98(8):e14697\u2013e14697. https:\/\/doi.org\/10.1097\/MD.0000000000014697","journal-title":"Medicine"},{"issue":"11","key":"260_CR74","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0025-6196(11)60670-8","volume":"84","author":"JC Schultz","year":"2009","unstructured":"Schultz JC, Hilliard AA, Cooper LT Jr, Rihal CS (2009) Diagnosis and treatment of viral myocarditis. Mayo Clin Proc 84(11):1001\u20131009. https:\/\/doi.org\/10.1016\/S0025-6196(11)60670-8","journal-title":"Mayo Clin Proc"},{"key":"260_CR75","doi-asserted-by":"crossref","unstructured":"Smith SC, Ladenson JH, Mason JW, Jaffe AS (1997) Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 95(1)","DOI":"10.1161\/01.CIR.95.1.163"},{"key":"260_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.carrev.2020.08.028","volume":"23","author":"K Sawalha","year":"2021","unstructured":"Sawalha K, Abozenah M, Kadado AJ et al (2021) Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovasc Revascular Med Include Mol Intervent 23:107\u2013113. https:\/\/doi.org\/10.1016\/j.carrev.2020.08.028","journal-title":"Cardiovasc Revascular Med Include Mol Intervent"},{"issue":"11","key":"260_CR77","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCRESAHA.118.313578","volume":"124","author":"C Tsch\u00f6pe","year":"2019","unstructured":"Tsch\u00f6pe C, Cooper LT, Torre-Amione G, van Linthout S (2019) Management of myocarditis-related cardiomyopathy in adults. Circ Res 124(11):1568\u20131583. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.313578","journal-title":"Circ Res"},{"issue":"24","key":"260_CR78","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"VM Ferreira","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 72(24):3158\u20133176. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.072","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"260_CR79","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","volume":"53","author":"MG Friedrich","year":"2009","unstructured":"Friedrich MG, Sechtem U, Schulz-Menger J et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 53(17):1475\u20131487. https:\/\/doi.org\/10.1016\/j.jacc.2009.02.007","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"260_CR80","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.hrtlng.2020.08.013","volume":"49","author":"JS Ho","year":"2020","unstructured":"Ho JS, Sia CH, Chan MY, Lin W, Wong RC (2020) Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung J Critical Care 49(6):681\u2013685. https:\/\/doi.org\/10.1016\/j.hrtlng.2020.08.013","journal-title":"Heart Lung J Critical Care"},{"issue":"24","key":"260_CR81","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","volume":"72","author":"MV Ferreira","year":"2018","unstructured":"Ferreira MV, Jeanette SM, Godtfred H et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation. J Am College Cardiol. 72(24):3158\u20133176. https:\/\/doi.org\/10.1016\/j.jacc.2018.09.072","journal-title":"J Am College Cardiol."},{"issue":"4","key":"260_CR82","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.carpath.2011.10.001","volume":"21","author":"O Leone","year":"2012","unstructured":"Leone O, Veinot JP, Angelini A et al (2012) 2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol 21(4):245\u2013274. https:\/\/doi.org\/10.1016\/j.carpath.2011.10.001","journal-title":"Cardiovasc Pathol"},{"key":"260_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(87)80363-5","author":"HT Aretz","year":"1987","unstructured":"Aretz HT (1987) Myocarditis: the Dallas criteria. Human Pathol. https:\/\/doi.org\/10.1016\/s0046-8177(87)80363-5","journal-title":"Human Pathol"},{"issue":"2","key":"260_CR84","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ccd.28959","volume":"97","author":"GG Secco","year":"2021","unstructured":"Secco GG, Tarantini G, Mazzarotto P et al (2021) Invasive strategy for COVID patients presenting with acute coronary syndrome: the first multicenter Italian experience. Catheter Cardiovasc Interv 97(2):195\u2013198. https:\/\/doi.org\/10.1002\/ccd.28959","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5874","key":"260_CR85","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1154315","volume":"320","author":"RM Anthony","year":"2008","unstructured":"Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV (2008) Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320(5874):373\u2013376. https:\/\/doi.org\/10.1126\/science.1154315","journal-title":"Science"},{"issue":"6","key":"260_CR86","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00059-004-2628-7","volume":"29","author":"B Maisch","year":"2004","unstructured":"Maisch B, Hufnagel G, K\u00f6lsch S et al (2004) Treatment of inflammatory dilated cardiomyopathy and (peri)myocarditis with immunosuppression and i.v. immunoglobulins. Herz 29(6):624\u2013636. https:\/\/doi.org\/10.1007\/s00059-004-2628-7","journal-title":"Herz"},{"issue":"2","key":"260_CR87","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/eurheartj\/ehaa190","volume":"42","author":"H Hu","year":"2021","unstructured":"Hu H, Ma F, Wei X, Fang Y (2021) Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J 42(2):206. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa190","journal-title":"Eur Heart J"},{"issue":"2","key":"260_CR88","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1536\/ihj.18-299","volume":"60","author":"X Huang","year":"2019","unstructured":"Huang X, Sun Y, Su G, Li Y, Shuai X (2019) Intravenous immunoglobulin therapy for acute myocarditis in children and adults. Int Heart J 60(2):359\u2013365. https:\/\/doi.org\/10.1536\/ihj.18-299","journal-title":"Int Heart J"},{"key":"260_CR89","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/ejhf.951","volume":"20","author":"C Tsch\u00f6pe","year":"2018","unstructured":"Tsch\u00f6pe C, van Linthout SS, Pieske B, K\u00fchl U (2018) Immunosuppression in lymphocytic myocarditis with parvovirus B19 presence. Eur J Heart Failure 20:609","journal-title":"Eur J Heart Failure"},{"key":"260_CR90","doi-asserted-by":"publisher","DOI":"10.15420\/ecr.2020.16","author":"M Abdelnabi","year":"2020","unstructured":"Abdelnabi M, Eshak N, Saleh Y, Almaghraby A (2020) Coronavirus disease 2019 myocarditis: insights into pathophysiology and management. Eur Cardiol Rev. https:\/\/doi.org\/10.15420\/ecr.2020.16","journal-title":"Eur Cardiol Rev"},{"issue":"10","key":"260_CR91","doi-asserted-by":"publisher","first-page":"CD004471","DOI":"10.1002\/14651858.CD004471.pub3","volume":"2013","author":"HS Chen","year":"2013","unstructured":"Chen HS, Wang W, Wu SN, Liu JP (2013) Corticosteroids for viral myocarditis. Cochrane Database Syst Rev 2013(10):CD004471\u2013CD004471. https:\/\/doi.org\/10.1002\/14651858.CD004471.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"260_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110825","volume":"133","author":"H Zhao","year":"2021","unstructured":"Zhao H, Zhu Q, Zhang C et al (2021) Tocilizumab combined with favipiravir in the treatment of COVID-19: a multicenter trial in a small sample size. Biomed Pharmacother 133:110825. https:\/\/doi.org\/10.1016\/j.biopha.2020.110825","journal-title":"Biomed Pharmacother"},{"key":"260_CR93","doi-asserted-by":"publisher","unstructured":"(2005) Part 7.3: management of symptomatic bradycardia and tachycardia. Circulation 112(24_supplement):IV-67\u2013IV-77. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.166558","DOI":"10.1161\/CIRCULATIONAHA.105.166558"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-022-00260-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-022-00260-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-022-00260-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:10:52Z","timestamp":1649153452000},"score":1,"resource":{"primary":{"URL":"https:\/\/tehj.springeropen.com\/articles\/10.1186\/s43044-022-00260-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1186\/s43044-022-00260-2","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"8 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}